Vimarsana
Biggest News Aggregation in the World

Current Shareholders News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Current Shareholders. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Current Shareholders Today - Breaking & Trending Today

Jamjoom Pharmaceuticals factory company announces results of the subscription period for individual investors - Vimarsana News

Jamjoom Pharmaceuticals factory company announces results of the subscription period for individual investors

The retail subscription process, comprising of a maximum of 2,100,000 representing 10% of the total Offer Shares, commenced on Tuesday, 30 May 2023 and ended on Thursday, 01 June 2023

Source: zawya.com
Canagold Resources : CAUTION – FORWARD LOOKING STATEMENTS - Form 6-K - Vimarsana News

Canagold Resources : CAUTION – FORWARD LOOKING STATEMENTS - Form 6-K

CAUTION - FORWARD LOOKING STATEMENTS Certain statements contained herein regarding the Company and its operations constitute "forward-looking statements" within the... | May 15, 2023

Little retail investor interest in Mankind Pharma IPO - Vimarsana News

Little retail investor interest in Mankind Pharma IPO

Mankind Pharma's IPO fails to attract enough retail investors, with the retail quota 8% unsubscribed. The company plans to raise ?4,326 crore through the IPO.

AOIC announces IPO, listing on Saudi Exchange's Main Market - Vimarsana News

AOIC announces IPO, listing on Saudi Exchange's Main Market

Abdullah Al Othaim Investment Company (AOIC), a leading mall, entertainment, fashion and F&B operator in KSA, will offer 30 million ordinary shares through an initial public offering (IPO) and list them on Saudi Exchange’s Main Market.

Aelis Farma, a Biopharmaceutical Company Developing a New Generation of Drugs for Brain Diseases, Launches Its Initial Public Offering on the Regulated Market of Euronext Paris - Vimarsana News

Aelis Farma, a Biopharmaceutical Company Developing a New Generation of Drugs for Brain Diseases, Launches Its Initial Public Offering on the Regulated Market of Euronext Paris

02.02.2022 - Regulatory News: Not to be distributed, directly or indirectly, in the United States of America, Canada, Australia, Japan or South Africa. Aelis Farma, a clinical-stage biopharmaceutical company specializing in the development of treatments for ...